Correspondence
National multicentric M13 Stem Cell Trial reports negative outcome – Need to look at VSELs as an alternative to bone marrow MNCs for cardiac regeneration
Volume 143 | Issue 6 | June 2016
Disclaimer:
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.